Trial Profile

Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cobicistat/darunavir (Primary) ; Darunavir (Primary)
Indications HIV-1 infections
Focus Pharmacokinetics

Most Recent Events

22 Jul 2020 Results of population pharmacokinetics model and simulation analysis based on exploration of reduced doses and frequency published in the Clinical Pharmacokinetics
30 Aug 2019 Status changed from active, no longer recruiting to completed.
17 Apr 2019 Planned End Date changed from 1 Mar 2019 to 1 Jul 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com